TY - JOUR
T1 - Prostate-specific antigen and other serum markers
T2 - Current concepts from the world health organization second international consultation on prostate cancer
AU - Brawer, M. K.
AU - Benson, M. C.
AU - Bostwick, D. G.
AU - Djavan, B.
AU - Lilja, H.
AU - Semjonow, A.
AU - Su, S.
AU - Zhou, Z.
PY - 1999
Y1 - 1999
N2 - Serum prostate-specific antigen is credited with dramatic advances in the early detection, screening, and management of men with prostatic carcinoma. There has been more than a twofold increase in the number of men diagnosed during the last decade, and prostate cancer has emerged as the most common non-skin cancer and the second leading cause of cancer death in men. This report summarizes the history and current status of prostate-specific antigen and other serum markers, incorporating consensus opinions from the Second International Consultation on Prostate Cancer held in Paris in June 1999.
AB - Serum prostate-specific antigen is credited with dramatic advances in the early detection, screening, and management of men with prostatic carcinoma. There has been more than a twofold increase in the number of men diagnosed during the last decade, and prostate cancer has emerged as the most common non-skin cancer and the second leading cause of cancer death in men. This report summarizes the history and current status of prostate-specific antigen and other serum markers, incorporating consensus opinions from the Second International Consultation on Prostate Cancer held in Paris in June 1999.
KW - Diagnosis
KW - Markers
KW - Prostate-specific antigen
UR - http://www.scopus.com/inward/record.url?scp=0033426835&partnerID=8YFLogxK
UR - https://pubmed.ncbi.nlm.nih.gov/10632122/
M3 - Review article
C2 - 10632122
AN - SCOPUS:0033426835
SN - 1081-0943
VL - 17
SP - 206
EP - 221
JO - Seminars in Urologic Oncology
JF - Seminars in Urologic Oncology
IS - 4
ER -
